ABVC BioPharma Inc.

NASDAQ: ABVC · Real-Time Price · USD
3.09
0.24 (8.42%)
At close: Aug 20, 2025, 3:59 PM
3.09
0.00%
After-hours: Aug 20, 2025, 07:41 PM EDT

ABVC BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-2.33M -944.19K 229.3K -186.56K -1.01M -2.93M -3.11M -3.37M -2.32M -1.9M -4.5M -3.78M -1.95M -6.09M -6.9M -1.89M -2.05M -1.2M
Depreciation & Amortization
80.83K 113.95K 179.32K 7.01K 13.3K 102.55K 7.58K 7.46K 7K 6.49K 6.43K 6.46K 5.49K 5.41K 3.27K 2.86K 2.94K 2.93K
Stock-Based Compensation
1.57M 48.77K -184.28K n/a 412.74K 2.03M 225.74K 817.74K 225.74K 366.49K 1.89M 225.74K 225.74K 4.69M 4.38M 225.74K 475.74K 225.74K
Other Working Capital
61.93K -61.93K -147.88K -127.75K -136.12K -198.25K 145.95K -7.91K 869.93K -113.34K 2.03M 2.38M -1.63M -1.53M -589.46K -887.69K 41.16K -67.59K
Other Non-Cash Items
-233.07K 260.92K -743.54K 338.66K 86.87K 530.1K 2.39M 1.3M 162.81K -1.52K -199.48K 533.69K 9.33K 9.5K -27.47K -40.57K 53.59K -76.61K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 151.39K -117.41K 81.69K n/a 896.05K 138.87K -83.25K -86.87K 1.01M -75.67K -60.36K -51.02K
Change in Working Capital
19.28K -19.28K 25.58K 12.61K -514.37K -338.61K -146.82K 1.79K 938.16K 28.14K 1.44M 2.36M -1.64M -1.53M -521.44K -910.58K 137.04K -318.79K
Operating Cash Flow
-894.17K -539.83K -493.61K 171.72K -1.01M -602K -479.46K -1.36M -899.83K -1.5M -461.07K -513.7K -3.43M -2.99M -2.06M -2.68M -1.44M -1.41M
Capital Expenditures
n/a n/a n/a -3 3.00 -4 21.2K -21.2K n/a n/a -89 -4.36K -22.03K -93.22K 281.95K n/a n/a -281.95K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -83.2K -1.52M n/a n/a -44.74K -214.2K n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a 154.17K -52.58K -440.57K n/a -83.2K -1.52M 93.22K n/a 3.15K n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 166.4K 3.04M n/a n/a -550.18K n/a n/a n/a
Other Investing Acitivies
-665.78K n/a n/a 3.00 -3 n/a -21.2K n/a -440.57K n/a -83.2K -1.52M -93.22K n/a 268.23K -128.2K -140.02K n/a
Investing Cash Flow
-665.78K n/a n/a n/a n/a n/a 154.17K -73.78K -440.57K n/a -83.29K -1.52M -22.03K -93.22K -41.59K -342.4K -140.02K -281.95K
Debt Repayment
n/a -29.25K -87.04K -179.13K 24.33K 312.1K 110.11K -1.82M -31.59K 3.21M n/a 350K n/a n/a 8.36K -107.1K -61.23K 1.78K
Common Stock Repurchased
n/a n/a -7.32K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.93M 46.34K 809.55K -131.04K 106.71K 217.98K n/a 2.43M n/a -1M n/a n/a n/a n/a n/a -950.43K -15.28K n/a
Financial Cash Flow
1.93M 428.76K 581.46K -145.39K 868.54K 924.15K 87.42K 1.66M -31.59K 2.21M -253.5K 603.5K 3.66M n/a 4.25M 5.82M -116.96K 42.23K
Net Cash Flow
n/a -104.25K 93.94K 27.1K 83.77K -57.78K -404.16K 378.75K -1.05M 400.15K -578.42K -1.63M 166.66K -3.13M 2.12M 2.79M -1.68M -1.67M
Free Cash Flow
-894.17K -539.83K -493.61K 171.72K -1.01M -602K -440.8K -1.38M -899.83K -1.5M -461.16K -518.06K -3.45M -3.09M -1.77M -2.68M -1.44M -1.7M